1-(4-(1-methyl-1H-pyrazol-4-yl)benzyl)-4-(4-(trifluoromethyl)phenyl)-1H-1,2,3-triazole

ID: ALA4525897

PubChem CID: 150336955

Max Phase: Preclinical

Molecular Formula: C20H16F3N5

Molecular Weight: 383.38

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2ccc(Cn3cc(-c4ccc(C(F)(F)F)cc4)nn3)cc2)cn1

Standard InChI:  InChI=1S/C20H16F3N5/c1-27-12-17(10-24-27)15-4-2-14(3-5-15)11-28-13-19(25-26-28)16-6-8-18(9-7-16)20(21,22)23/h2-10,12-13H,11H2,1H3

Standard InChI Key:  GQWMMMAUWHLIBA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    4.3472  -23.9481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0537  -24.3571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7594  -23.9465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7567  -23.1284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0425  -22.7227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3398  -23.1356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4623  -22.7162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1726  -23.1177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1763  -23.9384    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9580  -24.1885    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4374  -23.5224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9520  -22.8607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2546  -23.5186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6625  -24.2260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4790  -24.2227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8852  -23.5126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4690  -22.8044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6539  -22.8112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6419  -25.1815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6410  -24.3594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8588  -24.1061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3762  -24.7718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8602  -25.4363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5590  -24.7726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7023  -23.5078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1151  -24.2131    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.1068  -22.7977    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.5179  -23.5046    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 20  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 19  2  0
 22 24  1  0
 16 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4525897

    ---

Associated Targets(Human)

KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TEK Tclin Tyrosine-protein kinase TIE-2 (3348 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EA.hy 926 (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.38Molecular Weight (Monoisotopic): 383.1358AlogP: 4.41#Rotatable Bonds: 4
Polar Surface Area: 48.53Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.83CX LogP: 4.73CX LogD: 4.73
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -2.01

References

1. Shan Y, Si R, Wang J, Zhang Q, Zhou H, Song J, Zhang J, Chen Q..  (2019)  Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs.,  164  [PMID:30616052] [10.1016/j.ejmech.2018.12.067]

Source